Barrett, J. A., LaFrance, N. D., Coleman, R., Goldsmith, S. J., Stubbs, J. B., Petry, N. A., … Babich, J. W. (2009). Targeting Metastatic Prostate Cancer (PCa) Using I-123-MIP-1072 & I-123-MIP-1095: A Phase I Clinical Study in Patients. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 36, pp. 243–243). SPRINGER.

Barrett, J. A., N. D. LaFrance, R. Coleman, S. J. Goldsmith, J. B. Stubbs, N. A. Petry, S. Vallabhajosula, et al. “Targeting Metastatic Prostate Cancer (PCa) Using I-123-MIP-1072 & I-123-MIP-1095: A Phase I Clinical Study in Patients.” In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36:243–243. SPRINGER, 2009.

Barrett JA, LaFrance ND, Coleman R, Goldsmith SJ, Stubbs JB, Petry NA, et al. Targeting Metastatic Prostate Cancer (PCa) Using I-123-MIP-1072 & I-123-MIP-1095: A Phase I Clinical Study in Patients. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2009. p. 243–243.

Barrett, J. A., et al. “Targeting Metastatic Prostate Cancer (PCa) Using I-123-MIP-1072 & I-123-MIP-1095: A Phase I Clinical Study in Patients.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 36, no. SUPPL 2, SPRINGER, 2009, pp. 243–243.

Barrett JA, LaFrance ND, Coleman R, Goldsmith SJ, Stubbs JB, Petry NA, Vallabhajosula S, Maresca K, Femia F, Stabin MG, Babich JW. Targeting Metastatic Prostate Cancer (PCa) Using I-123-MIP-1072 & I-123-MIP-1095: A Phase I Clinical Study in Patients. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2009. p. 243–243.